SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Clinical trial NCT06873659 · RECRUITING

Trial details

NCT number: NCT06873659
Sponsor: Qurgen Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Gastric Cancer Liver Cancer

Start date: 2025-02-26
Primary completion: 2027-04-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.